Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis

BACKGROUND: Kawasaki disease (KD) is now the leading cause of acquired heart disease in children in developed countries. Intravenous immunoglobulin (IVIG) and aspirin were considered as the standard initial treatment of KD for decades. However, the optimal dose of aspirin has remained controversial....

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaolan, Yue, Peng, Liu, Lei, Tang, Changqing, Ma, Fan, Zhang, Yi, Wang, Chuan, Duan, Hongyu, Zhou, Kaiyu, Hua, Yimin, Wu, Gang, Li, Yifei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531010/
https://www.ncbi.nlm.nih.gov/pubmed/31117119
http://dx.doi.org/10.1371/journal.pone.0217274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531010/
https://www.ncbi.nlm.nih.gov/pubmed/31117119
http://dx.doi.org/10.1371/journal.pone.0217274

Ejemplares similares